Vivo Capital, LLC Genocea Biosciences, Inc. Transaction History

Vivo Capital, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 13, 2019	SELL	$2.9 - $4.07 $1.82 Million - $2.55 Million	-626,401 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$3.47 - $6.71 $2.17 Million - $4.2 Million	626,401 New	626,401 $2.46 Million

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.